 CAMBRIDGE, Mass., Feb. 24, 2021 GLOBE NEWSWIRE -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced its fourth-quarter 2020 financial results and provided a business update. 